Role of macrophage in the defense against intestinal cancers.
The capability of activated macrophages to kill tumor cells in vitro is now well documented. The tumoricidal activation of macrophages against intestinal tumor cells by different agents is described and the main hypothesis on the mechanisms of tumor cell killing in vitro are discussed. These in vitro results suggest that the macrophage can constitute an efficient effector cell in the defense against intestinal tumors. The distribution and ratio of macrophages in normal intestine and intestinal tumors is described. At the moment, potent activators of macrophages studied in vivo on experimental and human intestinal tumors give poor results or even enhance the growth of tumors. Macrophages may also interfere with the specific immune response in two directions by enhancing the immune response or decreasing it by elaboration of mediators such as prostaglandins.
D000818:Animals; D001500:BCG Vaccine / Q000627:therapeutic use; D003110:Colonic Neoplasms / Q000276:immunology / Q000473:pathology; D003602:Cytotoxicity, Immunologic; D004195:Disease Models, Animal; D006801:Humans; D007167:Immunotherapy; D066298:In Vitro Techniques; D007414:Intestinal Neoplasms / Q000276:immunology* / Q000473:pathology / Q000628:therapy; D007422:Intestines / Q000166:cytology / Q000276:immunology; D008262:Macrophage Activation; D008264:Macrophages / Q000276:immunology* / Q000473:pathology; D051379:Mice; D051381:Rats; D012004:Rectal Neoplasms / Q000276:immunology / Q000473:pathology
D001500:BCG Vaccine